These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
434 related articles for article (PubMed ID: 9066479)
1. General practitioners' perceptions of the tolerability of antidepressant drugs: a comparison of selective serotonin reuptake inhibitors and tricyclic antidepressants. Martin RM; Hilton SR; Kerry SM; Richards NM BMJ; 1997 Mar; 314(7081):646-51. PubMed ID: 9066479 [TBL] [Abstract][Full Text] [Related]
2. WITHDRAWN: Treatment discontinuation with selective serotonin reuptake inhibitors (SSRIs) versus tricyclic antidepressants (TCAs). Barbui C; Hotopf M; Freemantle N; Boynton J; Churchill R; Eccles MP; Geddes JR; Hardy R; Lewis G; Mason JM Cochrane Database Syst Rev; 2007 Jul; (3):CD002791. PubMed ID: 17636706 [TBL] [Abstract][Full Text] [Related]
3. Selective serotonin reuptake inhibitors versus tricyclic and heterocyclic antidepressants: comparison of drug adherence. Barbui C; Hotopf M; Freemantle N; Boynton J; Churchill R; Eccles MP; Geddes JR; Hardy R; Lewis G; Mason JM Cochrane Database Syst Rev; 2000; (4):CD002791. PubMed ID: 11034764 [TBL] [Abstract][Full Text] [Related]
4. The treatment of depression in UK general practice: selective serotonin reuptake inhibitors and tricyclic antidepressants compared. Lawrenson RA; Tyrer F; Newson RB; Farmer RD J Affect Disord; 2000 Aug; 59(2):149-57. PubMed ID: 10837883 [TBL] [Abstract][Full Text] [Related]
5. Treatment discontinuation with selective serotonin reuptake inhibitors compared with tricyclic antidepressants: a meta-analysis. Anderson IM; Tomenson BM BMJ; 1995 Jun; 310(6992):1433-8. PubMed ID: 7613276 [TBL] [Abstract][Full Text] [Related]
6. Efficacy and tolerability of selective serotonin reuptake inhibitors compared with tricyclic antidepressants in depression treated in primary care: systematic review and meta-analysis. MacGillivray S; Arroll B; Hatcher S; Ogston S; Reid I; Sullivan F; Williams B; Crombie I BMJ; 2003 May; 326(7397):1014. PubMed ID: 12742924 [TBL] [Abstract][Full Text] [Related]
7. Association between mortality from suicide in England and antidepressant prescribing: an ecological study. Morgan OW; Griffiths C; Majeed A BMC Public Health; 2004 Dec; 4():63. PubMed ID: 15613234 [TBL] [Abstract][Full Text] [Related]
8. GPs' perceptions of tolerability of selective serotonin reuptake inhibitors and tricyclic antidepressants. Research into long term use is needed. Bhatti N; Graffy J BMJ; 1997 Aug; 315(7107):547; author reply 548. PubMed ID: 9329322 [No Abstract] [Full Text] [Related]
10. Amitriptyline versus other types of pharmacotherapy for depression. Guaiana G; Barbui C; Hotopf M Cochrane Database Syst Rev; 2003; (2):CD004186. PubMed ID: 12804503 [TBL] [Abstract][Full Text] [Related]
11. A randomised controlled trial to compare the cost-effectiveness of tricyclic antidepressants, selective serotonin reuptake inhibitors and lofepramine. Peveler R; Kendrick T; Buxton M; Longworth L; Baldwin D; Moore M; Chatwin J; Goddard J; Thornett A; Smith H; Campbell M; Thompson C Health Technol Assess; 2005 May; 9(16):1-134, iii. PubMed ID: 15876362 [TBL] [Abstract][Full Text] [Related]
12. Antidepressant use patterns in clinical practices: comparisons among tricyclic antidepressants and selective serotonin reuptake inhibitors. Donoghue J Acta Psychiatr Scand Suppl; 2000; 403():57-61. PubMed ID: 11019936 [TBL] [Abstract][Full Text] [Related]
13. GPs' perceptions of tolerability of selective serotonin reuptake inhibitors and tricyclic antidepressants. Clinical assessments are liable to bias. Grace J BMJ; 1997 Aug; 315(7107):547; author reply 548. PubMed ID: 9329323 [No Abstract] [Full Text] [Related]
14. Incidence and prevalence of primary care antidepressant prescribing in children and young people in England, 1998-2017: A population-based cohort study. Jack RH; Hollis C; Coupland C; Morriss R; Knaggs RD; Butler D; Cipriani A; Cortese S; Hippisley-Cox J PLoS Med; 2020 Jul; 17(7):e1003215. PubMed ID: 32697803 [TBL] [Abstract][Full Text] [Related]
15. Prescribing selective serotonin reuptake inhibitors as strategy for prevention of suicide. Freemantle N; House A; Song F; Mason JM; Sheldon TA BMJ; 1994 Jul; 309(6949):249-53. PubMed ID: 7832842 [TBL] [Abstract][Full Text] [Related]
16. Effects of tricyclic antidepressants, selective serotonin reuptake inhibitors, and selective serotonin-norepinephrine reuptake inhibitors on the ocular surface. Ismayilov AS; Celikel G Arq Bras Oftalmol; 2022; 86(5):e20230068. PubMed ID: 35544938 [TBL] [Abstract][Full Text] [Related]
17. Antidepressant use and risk of adverse outcomes in older people: population based cohort study. Coupland C; Dhiman P; Morriss R; Arthur A; Barton G; Hippisley-Cox J BMJ; 2011 Aug; 343():d4551. PubMed ID: 21810886 [TBL] [Abstract][Full Text] [Related]
18. Orphan comparisons and indirect meta-analysis: a case study on antidepressant efficacy in dysthymia comparing tricyclic antidepressants, selective serotonin reuptake inhibitors, and monoamine oxidase inhibitors by using general linear models. Ballesteros J J Clin Psychopharmacol; 2005 Apr; 25(2):127-31. PubMed ID: 15738743 [TBL] [Abstract][Full Text] [Related]
19. Length of therapy with selective serotonin reuptake inhibitors and tricyclic antidepressants in Australia. McManus P; Mant A; Mitchell P; Dudley J Aust N Z J Psychiatry; 2004 Jun; 38(6):450-4. PubMed ID: 15209838 [TBL] [Abstract][Full Text] [Related]
20. An examination of the attitudes and practice of general practitioners in the diagnosis and treatment of depression in older people. Rothera I; Jones R; Gordon C Int J Geriatr Psychiatry; 2002 Apr; 17(4):354-8. PubMed ID: 11994890 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]